New developments in the diagnosis and treatment of thyroid cancer

DF Schneider, H Chen - CA: a cancer journal for clinicians, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Thyroid cancer exists in several forms. Differentiated
thyroid cancers include those with papillary and follicular histologies. These tumors exist …

Medullary, anaplastic, and metastatic cancers of the thyroid

SC Pitt, JF Moley - Seminars in oncology, 2010 - Elsevier
Thyroid cancer is the most common endocrine malignancy accounting for nearly 95% of
endocrine cancers according to the American Cancer Society. In 2009, more than 37,000 …

[HTML][HTML] Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors

Y Vedvyas, E Shevlin, M Zaman, IM Min… - JCI insight, 2016 - ncbi.nlm.nih.gov
Clinical monitoring of adoptive T cell transfer (ACT) utilizes serial blood analyses to discern
T cell activity. While useful, these data are 1-dimensional and lack spatiotemporal …

[HTML][HTML] Therapeutic options for advanced thyroid cancer

A Jayarangaiah, G Sidhu, J Brown… - … journal of clinical …, 2019 - clinsurggroup.us
Thyroid cancer can be largely classified as well-differentiated, poorly differentiated,
medullary and anaplastic. Differentiated thyroid cancer (DTC) includes follicular and …

[HTML][HTML] ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma

P Zhang, C Tao, T Shimura, AC Huang, N Kong, Y Dai… - Iscience, 2023 - cell.com
Treatment options for anaplastic thyroid cancer (ATC) and refractory papillary thyroid
carcinoma (PTC) are limited and outcomes remain poor. In this study, we determined via …

[HTML][HTML] Tackling Thyroid Cancer in Europe—The Challenges and Opportunities

D Horgan, D Führer-Sakel, P Soares, CV Alvarez… - Healthcare, 2022 - mdpi.com
Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the
thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how …

RET Proto-Oncogene Genetic Screening of Families with Multiple Endocrine Neoplasia Type 2 Optimizes Diagnostic and Clinical Management in China

XP Qi, XL Chen, JM Ma, ZF Du, J Fei, CP Yang… - Thyroid, 2012 - liebertpub.com
Background: Genetic screening for germline mutations in the RET proto-oncogene has been
extensively exploited worldwide to optimize the diagnostic and clinical management of …

[HTML][HTML] Thyroid cancer

R Arrangoiz, F Cordera, D Caba, E Moreno… - International Journal of …, 2019 - scirp.org
Thyroid tumors include those that originate from follicular cells and those that arise from
parafollicular cells (C cells). Differentiated thyroid cancer, which originates from follicular …

[HTML][HTML] Medullary thyroid carcinoma relapse reversed with dichloroacetate: A case report

D Flavin - Oncology Letters, 2010 - spandidos-publications.com
A 51-year-old male patient diagnosed with medullary thyroid carcinoma (MTC) in 2001, with
progression to lung metastases following adriamycin therapy, was then successfully treated …

New treatments and shifting paradigms in differentiated thyroid cancer management

WB Carter, JB Tourtelot, JG Savell… - Cancer …, 2011 - journals.sagepub.com
Background Although most thyroid cancer patients have an excellent prognosis, 10% of low-
risk cancers and 25% of high-risk cancers recur, with mortality rates in excess of 50% at 3 …